Korea Arlico Pharm Co., Ltd.
Exhibitors
Information
Korea Arlico Pharm successfully overcame tons of obstacles ‘Together’ for 30 years of journey and became one of 50 major pharma companies in Korea, listed at KOSDAQ in 2018.
Our sales networks & sales power nationwide made the consistent annual sales growth showing the average growth rate up to 23% from 2015 to 2022.
CMO specialized business of generic pharmaceuticals at PIC/S GMP facility, Arlico became one of the most reliable pharmaceutical manufacturers in Korea.
The aggressive investment to R&D for new and specialized pharmaceuticals strengthened the capability to create the new business area which led to big leap to top-ranking company.
Not a long story, but we have been doing our best efforts to meet customers’ needs through various channels in the global market and made the stable and gradual sales growth in Asia and currently expanding our market to CIS, Middle East, South America and Africa.
